The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney Disease

Haematopoietic insufficiency is the treatment target of lower-risk myelodysplastic syndrome (MDS). Although erythropoiesis-stimulating agents (ESAs) are generally effective for treating anaemia, resistance can develop. Hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) improves renal anaemia by pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Ryujiro, Goto, Naoki, Furuya, Daisuke, Kitahara, Toshihiko, Numata, Hiroki, Watanabe, Shigeki, Kawada, Hiroshi, Ando, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647131/
https://www.ncbi.nlm.nih.gov/pubmed/34949998
http://dx.doi.org/10.1159/000519568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647131/
https://www.ncbi.nlm.nih.gov/pubmed/34949998
http://dx.doi.org/10.1159/000519568

Ejemplares similares